Australia: Dr Patrick Thomas is an Affiliate Research Fellow within the Queensland Bladder Cancer Initiative (QBCI) at Queensland University of Technology, Australia. His research focuses on urological cancers and tumour immunology, with the goal of developing precision medicine tools to predict therapy response in bladder and prostate cancer patients.
His work centres on multiparametric immunophenotyping of tumour-localised immune cells, co-culture models for therapy prediction, and spatial profiling of high-risk and aggressive variants of bladder cancer.
Japan: Dr. Rikiya Taoka is an Associate Professor in the Department of Urology at Kagawa University. He earned his MD in 2001 and PhD in 2005, both from Kagawa University.
His academic career includes notable roles such as Assistant Professor at Kagawa University, Assistant Head Physician at Kurashiki Central Hospital, and Assistant Professor at Hyogo College of Medicine. He also served as a Visiting Assistant Professor at MD Anderson Cancer Center from 2013 to 2015.
Kuwait: Dr Saad Aldousari is Chairman of the Department of Surgery at Sabah Al-Ahmad Urology Center (SAUC), a tertiary referral centre for adult and paediatric urology patients. He is currently an Associate Professor in the Department of Surgery (Urology Division) at Kuwait University, and an Adjunct Associate Professor in the Department of Urology at MD Anderson Cancer Center in Houston, Texas, USA.
Dr Aldousari obtained his MBBCh degree from the Royal College of Surgeons in Ireland in 2003.
United States: Dr Shilpa Gupta is the Director of Genitourinary Medical Oncology at the Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. She obtained her medical degree from Lady Hardinge Medical College in New Delhi, India, and completed her residency in Internal Medicine at the University of Connecticut Health Center.
Dr Gupta completed fellowships in Haematology-Oncology and Genitourinary Oncology Translational Research at Thomas Jefferson University. She has held faculty positions at the H.
United Kingdom: Professor Ananya Choudhury is Chair of Clinical Oncology and Clinical Lead for Advanced Radiotherapy within the Division of Cancer Sciences at the University of Manchester, as well as Honorary Consultant in Clinical Oncology at The Christie NHS Trust, UK.
Professor Choudhury undertakes research that aims to optimise and personalise radiotherapy, using new techniques and imaging technology to deliver high doses while minimising side effects. Her work also focuses on predictive biomarkers to determine which patients will benefit from specific treatments.
South Africa: Prof Shingai Mutambirwa is Head of the Department of Urology at Dr George Mukhari Academic Hospital and Sefako Makgatho Health Sciences University in Pretoria, South Africa, a position he has held since 2008. He holds an MMed (Urology) from Medunsa and an FCS (Urol) degree. Prof. Mutambirwa is actively involved in teaching and research, participating in both university-led and industry-driven projects.
He is a founding member of the Prostate Cancer Foundation of South Africa and serves on several academic and professional boards,
